Point72 DIFC Ltd cut its position in shares of Oscar Health, Inc. (NYSE:OSCR – Free Report) by 51.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,086 shares of the company’s stock after selling 8,493 shares during the period. Point72 DIFC Ltd’s holdings in Oscar Health were worth $128,000 as of its most recent SEC filing.
Several other institutional investors have also made changes to their positions in OSCR. Avalon Trust Co acquired a new stake in Oscar Health in the first quarter valued at approximately $69,000. Point72 Hong Kong Ltd acquired a new stake in shares of Oscar Health in the 2nd quarter valued at $78,000. Quest Partners LLC bought a new stake in Oscar Health in the second quarter worth $93,000. Amalgamated Bank increased its position in Oscar Health by 27.7% during the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after buying an additional 1,458 shares during the last quarter. Finally, Focus Financial Network Inc. ADV bought a new position in Oscar Health during the fourth quarter valued at about $152,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.
Oscar Health Stock Performance
Shares of NYSE OSCR opened at $20.63 on Wednesday. Oscar Health, Inc. has a 12 month low of $4.72 and a 12 month high of $23.79. The company has a market cap of $4.89 billion, a P/E ratio of -51.58, a P/E/G ratio of 43.01 and a beta of 1.61. The business’s 50 day moving average is $18.70 and its two-hundred day moving average is $17.93. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.26.
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on OSCR shares. Piper Sandler reissued an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a research note on Tuesday, September 10th. Wells Fargo & Company boosted their price objective on shares of Oscar Health from $24.00 to $27.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 12th. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $24.17.
Get Our Latest Stock Report on Oscar Health
Insider Activity at Oscar Health
In other Oscar Health news, CFO Richard Scott Blackley sold 29,957 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $17.06, for a total value of $511,066.42. Following the completion of the transaction, the chief financial officer now owns 853,875 shares of the company’s stock, valued at approximately $14,567,107.50. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, insider Mario Schlosser sold 3,198 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $57,532.02. Following the sale, the insider now owns 76,982 shares of the company’s stock, valued at $1,384,906.18. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Richard Scott Blackley sold 29,957 shares of Oscar Health stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $17.06, for a total value of $511,066.42. Following the sale, the chief financial officer now directly owns 853,875 shares in the company, valued at $14,567,107.50. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 169,569 shares of company stock worth $3,007,069. Company insiders own 25.11% of the company’s stock.
Oscar Health Profile
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Articles
- Five stocks we like better than Oscar Health
- Find and Profitably Trade Stocks at 52-Week Lows
- Ready for Growth? Barrick Gold Stock Could Be the Answer
- How to Use the MarketBeat Stock Screener
- Trade Like a Member of Congress With These 2 ETFs
- Insider Trades May Not Tell You What You Think
- October’s Top 3 Stocks Revealed by MarketBeat’s MarketRank Tool
Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR – Free Report).
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.